221 related articles for article (PubMed ID: 31577035)
1. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.
Laterre PF; Berry SM; Blemings A; Carlsen JE; François B; Graves T; Jacobsen K; Lewis RJ; Opal SM; Perner A; Pickkers P; Russell JA; Windeløv NA; Yealy DM; Asfar P; Bestle MH; Muller G; Bruel C; Brulé N; Decruyenaere J; Dive AM; Dugernier T; Krell K; Lefrant JY; Megarbane B; Mercier E; Mira JP; Quenot JP; Rasmussen BS; Thorsen-Meyer HC; Vander Laenen M; Vang ML; Vignon P; Vinatier I; Wichmann S; Wittebole X; Kjølbye AL; Angus DC;
JAMA; 2019 Oct; 322(15):1476-1485. PubMed ID: 31577035
[TBL] [Abstract][Full Text] [Related]
2. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
3. Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.
Lewis RJ; Angus DC; Laterre PF; Kjølbye AL; van der Meulen E; Blemings A; Graves T; Russell JA; Carlsen JE; Jacobsen K; Yealy DM; Opal SM; Windeløv NA; François B; Perner A; Pickkers P; Berry SM
Ann Am Thorac Soc; 2018 Feb; 15(2):250-257. PubMed ID: 29388815
[TBL] [Abstract][Full Text] [Related]
4. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
5. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
Sevransky JE; Rothman RE; Hager DN; Bernard GR; Brown SM; Buchman TG; Busse LW; Coopersmith CM; DeWilde C; Ely EW; Eyzaguirre LM; Fowler AA; Gaieski DF; Gong MN; Hall A; Hinson JS; Hooper MH; Kelen GD; Khan A; Levine MA; Lewis RJ; Lindsell CJ; Marlin JS; McGlothlin A; Moore BL; Nugent KL; Nwosu S; Polito CC; Rice TW; Ricketts EP; Rudolph CC; Sanfilippo F; Viele K; Martin GS; Wright DW;
JAMA; 2021 Feb; 325(8):742-750. PubMed ID: 33620405
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
He X; Su F; Taccone FS; Laporte R; Kjølbye AL; Zhang J; Xie K; Moussa MD; Reinheimer TM; Vincent JL
Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
[TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
9. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
Ibarra-Estrada M; Kattan E; Aguilera-González P; Sandoval-Plascencia L; Rico-Jauregui U; Gómez-Partida CA; Ortiz-Macías IX; López-Pulgarín JA; Chávez-Peña Q; Mijangos-Méndez JC; Aguirre-Avalos G; Hernández G
Crit Care; 2023 Mar; 27(1):110. PubMed ID: 36915146
[TBL] [Abstract][Full Text] [Related]
10. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
[TBL] [Abstract][Full Text] [Related]
11. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
[TBL] [Abstract][Full Text] [Related]
13. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial.
Annane D; Siami S; Jaber S; Martin C; Elatrous S; Declère AD; Preiser JC; Outin H; Troché G; Charpentier C; Trouillet JL; Kimmoun A; Forceville X; Darmon M; Lesur O; Reignier J; Abroug F; Berger P; Clec'h C; Cousson J; Thibault L; Chevret S;
JAMA; 2013 Nov; 310(17):1809-17. PubMed ID: 24108515
[TBL] [Abstract][Full Text] [Related]
15. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
Hernández G; Ospina-Tascón GA; Damiani LP; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Granda-Luna V; Cavalcanti AB; Bakker J; ; Hernández G; Ospina-Tascón G; Petri Damiani L; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Cavalcanti AB; Bakker J; Hernández G; Alegría L; Ferri G; Rodriguez N; Holger P; Soto N; Pozo M; Bakker J; Cook D; Vincent JL; Rhodes A; Kavanagh BP; Dellinger P; Rietdijk W; Carpio D; Pavéz N; Henriquez E; Bravo S; Valenzuela ED; Vera M; Dreyse J; Oviedo V; Cid MA; Larroulet M; Petruska E; Sarabia C; Gallardo D; Sanchez JE; González H; Arancibia JM; Muñoz A; Ramirez G; Aravena F; Aquevedo A; Zambrano F; Bozinovic M; Valle F; Ramirez M; Rossel V; Muñoz P; Ceballos C; Esveile C; Carmona C; Candia E; Mendoza D; Sanchez A; Ponce D; Ponce D; Lastra J; Nahuelpán B; Fasce F; Luengo C; Medel N; Cortés C; Campassi L; Rubatto P; Horna N; Furche M; Pendino JC; Bettini L; Lovesio C; González MC; Rodruguez J; Canales H; Caminos F; Galletti C; Minoldo E; Aramburu MJ; Olmos D; Nin N; Tenzi J; Quiroga C; Lacuesta P; Gaudín A; Pais R; Silvestre A; Olivera G; Rieppi G; Berrutti D; Ochoa M; Cobos P; Vintimilla F; Ramirez V; Tobar M; García F; Picoita F; Remache N; Granda V; Paredes F; Barzallo E; Garcés P; Guerrero F; Salazar S; Torres G; Tana C; Calahorrano J; Solis F; Torres P; Herrera L; Ornes A; Peréz V; Delgado G; López A; Espinosa E; Moreira J; Salcedo B; Villacres I; Suing J; Lopez M; Gomez L; Toctaquiza G; Cadena Zapata M; Orazabal MA; Pardo Espejo R; Jimenez J; Calderón A; Paredes G; Barberán JL; Moya T; Atehortua H; Sabogal R; Ortiz G; Lara A; Sanchez F; Hernán Portilla A; Dávila H; Mora JA; Calderón LE; Alvarez I; Escobar E; Bejarano A; Bustamante LA; Aldana JL
JAMA; 2019 Feb; 321(7):654-664. PubMed ID: 30772908
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
Moskowitz A; Huang DT; Hou PC; Gong J; Doshi PB; Grossestreuer AV; Andersen LW; Ngo L; Sherwin RL; Berg KM; Chase M; Cocchi MN; McCannon JB; Hershey M; Hilewitz A; Korotun M; Becker LB; Otero RM; Uduman J; Sen A; Donnino MW;
JAMA; 2020 Aug; 324(7):642-650. PubMed ID: 32809003
[TBL] [Abstract][Full Text] [Related]
17. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.
Lyu QQ; Zheng RQ; Chen QH; Yu JQ; Shao J; Gu XH
Crit Care; 2022 Sep; 26(1):295. PubMed ID: 36171582
[TBL] [Abstract][Full Text] [Related]
18. The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*.
Maybauer MO; Maybauer DM; Enkhbaatar P; Laporte R; Wiśniewska H; Traber LD; Lin C; Fan J; Hawkins HK; Cox RA; Wiśniewski K; Schteingart CD; Landry DW; Rivière PJ; Traber DL
Crit Care Med; 2014 Jul; 42(7):e525-e533. PubMed ID: 24674922
[TBL] [Abstract][Full Text] [Related]
19. Selepressin, a novel selective V
Milano SP; Boucheix OB; Reinheimer TM
Peptides; 2020 Jul; 129():170318. PubMed ID: 32330539
[TBL] [Abstract][Full Text] [Related]
20. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
Whitehouse T; Hossain A; Perkins GD; Gordon AC; Bion J; Young D; McAuley D; Singer M; Lord J; Gates S; Veenith T; MacCallum NS; Yeung J; Innes R; Welters I; Boota N; Skilton E; Ghuman B; Hill M; Regan SE; Mistry D; Lall R;
JAMA; 2023 Nov; 330(17):1641-1652. PubMed ID: 37877587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
